Stay updated on Pembrolizumab and SRS for Brain Metastases in Breast Cancer: Clinical Trial
Sign up to get notified when there's something new on the Pembrolizumab and SRS for Brain Metastases in Breast Cancer: Clinical Trial page.

Latest updates to the Pembrolizumab and SRS for Brain Metastases in Breast Cancer: Clinical Trial page
- Check7 days agoNo Change Detected
- Check14 days agoChange DetectedRevision: v3.4.2 is now displayed on the page. The funding-status notice corresponding to Revision: v3.4.1 has been removed.SummaryDifference0.4%

- Check21 days agoChange DetectedAdded a site-wide notice about a lapse in government funding at the top of the page and updated the revision to v3.4.1. The previous revision tag v3.4.0 was removed.SummaryDifference0.4%

- Check28 days agoChange DetectedThe page now includes a Show glossary option and updates footer/metadata labels to 'Last Update Submitted that Met QC Criteria,' 'No FEAR Act Data,' and 'Revision: v3.4.0' (replacing the previous 'No FEAR Act data' and 'Revision: v3.3.4'). This change is limited to UI/metadata text and does not affect the study content.SummaryDifference0.2%

- Check42 days agoChange DetectedFooter revision updated from v3.3.3 to v3.3.4 on the Study Details page. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.1%

- Check64 days agoChange DetectedAdded a New York location under the Locations section. Removed the HHS Vulnerability Disclosure and the New York Locations link, and updated the page revision to v3.3.3.SummaryDifference0.2%

- Check92 days agoChange DetectedRevision metadata updated: added v3.3.2 and removed v3.2.0.SummaryDifference0.1%

Stay in the know with updates to Pembrolizumab and SRS for Brain Metastases in Breast Cancer: Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Pembrolizumab and SRS for Brain Metastases in Breast Cancer: Clinical Trial page.